Jiang‐Shan Tan

729 total citations
59 papers, 428 citations indexed

About

Jiang‐Shan Tan is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Internal Medicine. According to data from OpenAlex, Jiang‐Shan Tan has authored 59 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 15 papers in Genetics and 12 papers in Internal Medicine. Recurrent topics in Jiang‐Shan Tan's work include Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Genetic Associations and Epidemiology (10 papers). Jiang‐Shan Tan is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Genetic Associations and Epidemiology (10 papers). Jiang‐Shan Tan collaborates with scholars based in China, Netherlands and Italy. Jiang‐Shan Tan's co-authors include Lu Hua, Song Hu, Ningning Liu, Tingting Guo, Mengjin Hu, Yuejin Yang, Jingang Yang, Qiujin Qian, Yan Wu and Lei Jia and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Jiang‐Shan Tan

49 papers receiving 424 citations

Peers

Jiang‐Shan Tan
Daniela Zanetti United States
Jiang‐Shan Tan
Citations per year, relative to Jiang‐Shan Tan Jiang‐Shan Tan (= 1×) peers Daniela Zanetti

Countries citing papers authored by Jiang‐Shan Tan

Since Specialization
Citations

This map shows the geographic impact of Jiang‐Shan Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang‐Shan Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang‐Shan Tan more than expected).

Fields of papers citing papers by Jiang‐Shan Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang‐Shan Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang‐Shan Tan. The network helps show where Jiang‐Shan Tan may publish in the future.

Co-authorship network of co-authors of Jiang‐Shan Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang‐Shan Tan. A scholar is included among the top collaborators of Jiang‐Shan Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang‐Shan Tan. Jiang‐Shan Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Jiang‐Shan, Jun Zhu, Lulu Wang, et al.. (2025). Evaluation of the ABC pathway in patients with atrial fibrillation: A machine learning cluster analysis. IJC Heart & Vasculature. 57. 101621–101621. 1 indexed citations
3.
Gao, Qiannan, Zhiqin Wang, Cui Liu, et al.. (2025). Integration of spatial and single-cell transcriptomic analysis uncovers cellular and molecular alterations in the hypertensive brain. Life Sciences. 385. 124107–124107.
4.
Zhu, Jun, Jiang‐Shan Tan, Lulu Wang, et al.. (2024). Rate control or rhythm control in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention. Heliyon. 10(15). e35218–e35218. 2 indexed citations
5.
Tan, Jiang‐Shan, Yanmin Yang, Jingyang Wang, et al.. (2024). Diabetes mellitus, glycemic traits, SGLT2 inhibition, and risk of pulmonary arterial hypertension: A Mendelian randomization study. BioScience Trends. 18(1). 94–104. 4 indexed citations
6.
Zhang, Han, Juan Wang, Xing‐hui Shao, et al.. (2024). The Application of Artificial Intelligence in Atrial Fibrillation Patients: From Detection to Treatment. Reviews in Cardiovascular Medicine. 25(7). 257–257. 4 indexed citations
7.
Li, Xin, Jiang‐Shan Tan, Jing Xu, et al.. (2024). Causal impact of gut microbiota and associated metabolites on pulmonary arterial hypertension: a bidirectional Mendelian randomization study. BMC Pulmonary Medicine. 24(1). 185–185. 2 indexed citations
9.
Guo, Tingting, Chaowu Yan, Xin Gao, et al.. (2023). Untargeted metabolomics reveal the metabolic profile of normal pulmonary circulation. Respiratory Medicine. 217. 107369–107369. 6 indexed citations
10.
Tan, Jiang‐Shan, et al.. (2023). Genetic predisposition between coronavirus disease 2019 and rheumatic diseases: A 2‐sample Mendelian randomization study. International Journal of Rheumatic Diseases. 26(4). 710–717. 5 indexed citations
11.
Liu, Ningning, Jiang‐Shan Tan, Lu Liu, et al.. (2023). Roles of obesity in mediating the causal effect of attention-deficit/hyperactivity disorder on diabetes. Epidemiology and Psychiatric Sciences. 32. e32–e32. 12 indexed citations
12.
Hu, Song, et al.. (2023). Causal relationships of circulating amino acids with cardiovascular disease: a trans-ancestry Mendelian randomization analysis. Journal of Translational Medicine. 21(1). 699–699. 20 indexed citations
13.
Xu, Wei, Yanmin Yang, Jun Zhu, et al.. (2022). Left Atrial Diameter and the Risk of Thromboembolism in Patients with Left Ventricular Noncompaction. Journal of Cardiovascular Development and Disease. 9(12). 426–426. 1 indexed citations
14.
Hu, Mengjin, Jiang‐Shan Tan, & Yuejin Yang. (2022). Comparison of Six Different Percutaneous Coronary Intervention Guidance Modalities. Journal of Cardiovascular Development and Disease. 9(10). 343–343. 2 indexed citations
15.
Liu, Zhiqiang, et al.. (2022). Clinical and Safety Outcomes Associated with Extended Treatment of Venous Thromboembolism: A Network Meta-Analysis. Journal of Cardiovascular Development and Disease. 9(12). 414–414. 3 indexed citations
16.
Wu, Yan, Song Hu, Xinxin Yan, et al.. (2022). Chronic Thromboembolic Pulmonary Hypertension in Females: Clinical Features and Survival. Journal of Cardiovascular Development and Disease. 9(9). 308–308. 1 indexed citations
17.
Tan, Jiang‐Shan, Mengjin Hu, Yanmin Yang, & Yuejin Yang. (2022). Genetic Predisposition to Low-Density Lipoprotein Cholesterol May Increase Risks of Both Individual and Familial Alzheimer's Disease. Frontiers in Medicine. 8. 798334–798334. 14 indexed citations
18.
Liu, Ningning, et al.. (2021). Genetic Predisposition Between COVID-19 and Four Mental Illnesses: A Bidirectional, Two-Sample Mendelian Randomization Study. Frontiers in Psychiatry. 12. 746276–746276. 28 indexed citations
19.
Hu, Song, Jiang‐Shan Tan, Sheng Liu, et al.. (2021). Development and Validation of a Nomogram for Predicting the Long-Term Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension. The American Journal of Cardiology. 163. 109–116. 2 indexed citations
20.
Tan, Jiang‐Shan, Xinxin Yan, Yan Wu, et al.. (2021). Rare variants in MTHFR predispose to occurrence and recurrence of pulmonary embolism. International Journal of Cardiology. 331. 236–242. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026